Source: Citybizlist

Carisma: Carisma Therapeutics Provides Corporate Updates

Carisma Therapeutics Inc. (Nasdaq: CARM) today announced that its Board of Directors has approved a revised operating plan focused on... Read MoreThe post Carisma Therapeutics Provides Corporate Updates appeared first on citybiz.

Read full article »
Carisma's Competitors | Carisma's News | Carisma's Financials
Stay up-to-date with the latest news on Carisma
Annual Revenue
$5.0-25M
Employees
100-250
Steven Kelly's photo - President & CEO of Carisma

President & CEO

Steven Kelly

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Carisma